Combined analysis of PHOX2B at two time points and its value for further risk stratification in high-risk neuroblastoma.

MRD risk stratification based on PHOX2B levels at two time points (after two and six cycles of induction chemotherapy) provided a stratification system for high-risk NB, which successfully predicted treatment outcomes. Our results present an effective method for further stratification of high-risk NB.